255 related articles for article (PubMed ID: 30054425)
1. A regulatory circuitry comprising TP53,
Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.
Tan M; Wu J; Cai Y
Biochem Biophys Res Commun; 2013 Sep; 438(4):673-9. PubMed ID: 23939044
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
[TBL] [Abstract][Full Text] [Related]
4. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
Lee JK; Kim KC
Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322
[TBL] [Abstract][Full Text] [Related]
5. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex.
Fritsch L; Robin P; Mathieu JR; Souidi M; Hinaux H; Rougeulle C; Harel-Bellan A; Ameyar-Zazoua M; Ait-Si-Ali S
Mol Cell; 2010 Jan; 37(1):46-56. PubMed ID: 20129054
[TBL] [Abstract][Full Text] [Related]
6. MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.
Sun DM; Tang BF; Li ZX; Guo HB; Cheng JL; Song PP; Zhao X
Sci Rep; 2018 May; 8(1):8007. PubMed ID: 29789623
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
9. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53.
Fei Q; Shang K; Zhang J; Chuai S; Kong D; Zhou T; Fu S; Liang Y; Li C; Chen Z; Zhao Y; Yu Z; Huang Z; Hu M; Ying H; Chen Z; Zhang Y; Xing F; Zhu J; Xu H; Zhao K; Lu C; Atadja P; Xiao ZX; Li E; Shou J
Nat Commun; 2015 Oct; 6():8651. PubMed ID: 26471002
[TBL] [Abstract][Full Text] [Related]
10. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
[TBL] [Abstract][Full Text] [Related]
11. Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
Ueshima S; Fang J
Oncogene; 2022 Jun; 41(24):3370-3380. PubMed ID: 35546351
[TBL] [Abstract][Full Text] [Related]
12. Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation.
Singh SK; Bahal R; Rasmussen TP
Exp Cell Res; 2020 Oct; 395(2):112216. PubMed ID: 32768498
[TBL] [Abstract][Full Text] [Related]
13. Jarid2 (Jumonji, AT rich interactive domain 2) regulates NOTCH1 expression via histone modification in the developing heart.
Mysliwiec MR; Carlson CD; Tietjen J; Hung H; Ansari AZ; Lee Y
J Biol Chem; 2012 Jan; 287(2):1235-41. PubMed ID: 22110129
[TBL] [Abstract][Full Text] [Related]
14. Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression.
Liu H; Ma Y; Liu C; Li P; Yu T
Open Biol; 2018 Oct; 8(10):. PubMed ID: 30305431
[TBL] [Abstract][Full Text] [Related]
15. SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.
Sun QY; Ding LW; Xiao JF; Chien W; Lim SL; Hattori N; Goodglick L; Chia D; Mah V; Alavi M; Kim SR; Doan NB; Said JW; Loh XY; Xu L; Liu LZ; Yang H; Hayano T; Shi S; Xie D; Lin DC; Koeffler HP
J Pathol; 2015 Mar; 235(4):559-70. PubMed ID: 25404354
[TBL] [Abstract][Full Text] [Related]
16. p53 down-regulates SETDB1 gene expression during paclitaxel induced-cell death.
Noh HJ; Kim KA; Kim KC
Biochem Biophys Res Commun; 2014 Mar; 446(1):43-8. PubMed ID: 24565839
[TBL] [Abstract][Full Text] [Related]
17. Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates.
Binda O; LeRoy G; Bua DJ; Garcia BA; Gozani O; Richard S
Epigenetics; 2010; 5(8):767-75. PubMed ID: 21124070
[TBL] [Abstract][Full Text] [Related]
18. The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.
Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
Biochem Biophys Res Commun; 2012 Feb; 418(3):547-52. PubMed ID: 22290228
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.
Zheng ZH; Wu DM; Fan SH; Zhang ZF; Chen GQ; Lu J
J Cell Biochem; 2019 Nov; 120(11):18724-18735. PubMed ID: 31219199
[TBL] [Abstract][Full Text] [Related]
20. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
Liu B; Li J; Zheng M; Ge J; Li J; Yu P
Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
